课题基金 / 基金详情

TRPV6 Calcium Channel Peptide Antagonists as Novel Anti-myeloma and Anti-resorptive agents

TRPV6 Calcium Channel Peptide Antagonists as Novel Anti-myeloma and Anti-resorptive agents
TRPV6 钙通道肽拮抗剂作为新型抗骨髓瘤和抗再吸收剂
批准号：
345748
负责人：
Murugesan Alli
金额：
$0.07万
依托单位：
University of New Brunswick (St. John)
依托单位国家：
加拿大
项目类别：
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-01-01 至 2017-01-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=345748&lang=en
关键词：
Ics Travel Awards

项目摘要

项目成果

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Multiple myeloma, the bone marrow cancer and its associated bone disease are generally incurable. Hence, better treatments are needed to block the genes or proteins involved in the disease. The calcium channel, TRPV6 is over produced in several cancers an
期刊论文(0)
专著(0)
科研奖励(0)
会议论文